Thyroxine replacement: a clinical endocrinologist’s viewpoint

Vinay Eligar(Cardiff University), Colin Dayan(University of Birmingham), Peter Taylor(University Hospital of Wales), GP Leese(University of Dundee), OE Okosieme(Cwm Taf University Health Board)
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
April 28, 2016
10.1177/0004563216642255
Cited by 72

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315
Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and Risks
|JAMA Internal Medicine|2013|299